publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
steril
nonsteril
clinic
sampl
new
molecular
assay
j
clin
microbiol
huletski
giroux
r
rossbach
v
et
al
new
realtim
pcr
assay
rapid
detect
methicillinresist
staphylococcu
aureu
directli
specimen
contain
mixtur
staphylococci
studi
review
episod
periton
dialysi
pd
relat
periton
patient
overal
rate
periton
episod
year
pd
decreas
episod
year
incid
periton
caus
coagulaseneg
staphylococci
declin
episod
year
pd
coincid
reduct
use
spike
pd
set
respons
rate
antibiot
throughout
period
percentag
case
requir
modif
initi
empir
antibiot
regimen
rose
indic
treatment
individualis
periton
import
caus
treatment
failur
periton
dialysi
pd
patient
periton
common
follow
initi
develop
pd
incid
decreas
markedli
past
year
probabl
result
improv
connect
technolog
periton
rate
nowaday
less
one
episod
patientmonth
seri
present
studi
describ
chang
distribut
caus
organ
pdrelat
periton
period
singl
centr
hong
kong
episod
pdrelat
periton
renal
unit
princ
wale
hospit
hong
kong
review
total
episod
periton
patient
identifi
data
complet
assur
computeris
renal
registri
diagnosi
periton
base
least
two
follow
criteria
abdomin
pain
cloudi
periton
dialysi
effluent
pde
leukocytosi
pde
white
blood
cell
ml
posit
gramstain
cultur
pde
episod
periton
eosinophilia
neg
bacteri
cultur
exclud
bacteri
cultur
pde
perform
throughout
period
bactalert
bottl
organon
teknika
durham
nc
usa
accord
recommend
intern
societi
periton
dialysi
ispd
isol
identif
bacteria
well
determin
antibiot
sensit
perform
accord
ispd
guidelin
overal
clinic
manag
patient
describ
previous
empir
treatment
periton
summaris
tabl
gener
follow
ispd
guidelin
amend
time
antibiot
regimen
individu
patient
modifi
cultur
result
avail
appropri
antibiot
therapi
continu
day
treatment
respons
defin
complet
resolut
periton
antibiot
alon
without
relaps
cathet
remov
relaps
defin
recurr
periton
caus
organ
within
day
complet
antibiot
therapi
patient
follow
least
month
follow
complet
treatment
followup
data
assur
comput
manag
system
hong
kong
hospit
author
baselin
demograph
data
patient
similar
overal
pd
popul
report
previous
overal
rate
periton
episod
year
pd
microbiolog
caus
summaris
tabl
gradual
reduct
rate
periton
observ
period
episod
year
pd
episod
year
pd
incid
gramposit
cultureneg
periton
fell
remain
low
also
gradual
declin
incid
gramneg
periton
individu
bacteri
speci
consid
substanti
declin
incid
periton
caus
coagulaseneg
staphylococci
cn
less
mark
declin
staphylococcu
aureu
periton
incid
periton
caus
streptococcu
spp
remain
static
incid
periton
caus
cn
declin
episod
year
pd
remain
static
incid
periton
caus
pseudomona
spp
also
declin
episod
year
pd
contrast
incid
periton
caus
escherichia
coli
klebsiella
spp
remain
static
progress
reduct
use
spike
set
pd
parallel
declin
gramposit
periton
averag
rate
respons
antibiot
therapi
episod
requir
cathet
remov
combin
cefazolin
ceftazidim
regimen
recommend
current
guidelin
ispd
yield
respons
rate
rate
respons
antibiot
therapi
remain
static
period
detail
shown
howev
percentag
case
requir
alter
antibiot
regimen
rose
present
studi
found
overal
incid
pdrelat
periton
decreas
half
studi
period
specif
organ
examin
incid
periton
caus
cn
decreas
incid
caus
aureu
halv
declin
incid
gramposit
periton
unexpect
find
agre
gener
incid
periton
decreas
markedli
result
improv
connect
technolog
almost
patient
present
seri
use
disconnect
system
sinc
incid
gramposit
periton
remain
low
static
level
support
role
disconnect
system
interestingli
incid
gramposit
periton
show
signific
decreas
precis
reason
decreas
remain
unknown
may
result
outbreak
sever
acut
respiratori
syndrom
sar
hong
kong
reinforc
person
hygien
asept
precaut
taken
patient
attent
precaut
prove
reduc
rate
infect
pd
patient
increas
percentag
case
requir
alter
antibiot
regimen
suggest
antibiot
resist
becom
increasingli
common
increas
preval
infect
pd
patient
caus
methicillinresist
cn
note
holley
et
al
recent
kim
et
al
unfortun
data
regard
pattern
antibiot
resist
avail
current
retrospect
analysi
summari
gradual
declin
observ
incid
pdrelat
periton
past
year
appear
relat
partli
increas
utilis
disconnect
pd
system
howev
increas
need
modifi
initi
empir
antibiot
regimen
period
indic
treatment
tailor
individu
studi
support
chines
univers
hong
kong
research
account
number
thank
medic
nurs
staff
renal
unit
princ
wale
hospit
shatin
hong
kong
meticul
mainten
renal
registri
databas
